Eli Lilly’s weight loss injection tirzepatide, found in popular drugs Mounjaro and Zepbound, shows potential in treating sleep apnea according to recent research, enhancing the argument for broader insurance coverage of GLP-1 drugs due to their diverse health benefits beyond...
The question of whether semaglutide or other GlP-1’s such as Mounjaro, drugs primarily known for their efficacy in treating type 2 diabetes and weight loss, offers cardiovascular benefits to non-diabetic patients has been addressed by a groundbreaking study presented recently....